there were duplicate publications of the study, and only the version with the most complete data was retained
Ferrucci R, Cortese F, Bianchi M, Pittera D, Turrone R, Bocci T, et al
Nature Reviews Endocrinology (2013) 12
Thank you, Espeegee
Clinical trials support these findings, revealing measurable improvements in hair thickness, reduced shedding, and improved hair vitality
Typical Starting Protocol Sermorelin: 100-200 mcg subcutaneous CJC-1295 (no DAC / Mod GRF 1-29): 100-200 mcg subcutaneous Both injected simultaneously, same syringe or adjacent sites, at bedtime Frequency: 5 nights per week (Monday through Friday), cycling off weekends to reduce pituitary desensitization risk Total GHRH-equivalent stimulus per injection in the stack is therefore 200-400 mcg, which is within the dose range studied in sermorelin monotherapy trials [1] and in the Jett pharmacokinetic study for CJC-1295 [2]